Navigation Links
Common algae helps illustrate mammalian brain electrical circuitry

Mice whose brain cells respond to a flash of light are providing insight into the complexities of the sense of smell and may ultimately yield a better understanding of how the human brain works.

Investigators at Duke University Medical Center and the Howard Hughes Medical Institute have engineered a strain of mice whose olfactory brain cells "fire" when exposed to light. This was accomplished by inserting into the cells a gene naturally present in green algae that "turns on" when exposed to light and enables the algae to swim toward the light.

When the researchers shined light on the areas of the brain involved in smell, they could follow in real time what areas of the brain were reacting and where the signals went by seeing differences in electrical current that indicated the presence of the algae gene.

"This work provides a new method in live animals that will define the experimental approach for studying of mammalian neural circuitry in the coming decade," said Michael Ehlers, M.D., Ph.D., a Duke neurobiologist and Howard Hughes Medical Institute investigator.

The researchers published their findings in the April 19, 2007, issue of the journal Neuron. The research was supported by the National Institutes of Health and the Howard Hughes Medical Institute.

"This mouse model and its future variants mark the first use of genetically produced light activation in the study of the intact mammalian brain, and we believe this advance in nerve circuit mapping will be to neurobiology what microarray technology has been to genomic science -- a fundamental breakthrough," Ehlers said. Microarray technology enables scientists to screen thousands of genes at once to look for clusters of genes that may be involved in disease.

Although there are many approaches to studying how different nerve cells in the brain react to stimuli from the environment, this mouse model is the first to be able to provide real-time mapping of bra
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
2. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
3. Men Estimate Mens Risks Of Common Disorders Higher Than Women Do, And Vice Versa
4. Use of Antibiotics for Acne May Increase Risk of Common Illness
5. Common viruses may cause cancer
6. Common alternative treatment for liver disease is found to be ineffective
7. Common molecular signature identified in solid tumors
8. Common bacteria pirate natural mechanism to get inside cells
9. Commonly used antidepressants may also affect human immune system
10. Common practices at petting zoos put visitors at risk
11. Common enzyme is a key player in DNA repair

Post Your Comments:
(Date:12/2/2009)...other foods have done more than raise public aware...quietly fueling a boom in the market for food test...tions. That,s the topic of the two-part cover stor...News , (C&EN) ACS, weekly newsmagazine. , C&EN A...ondent Marc Reisch point out that food safety is a...
(Date:12/2/2009)... you, at least if you are a mammal cell. , Resea...ogy Center have shown that in healthy cells, a bun...nucleus, its genetic storehouse, in its proper pla... nuclear shape, the researchers say, could provide...such as cancer, muscular dystrophy and the age-acc...
(Date:12/2/2009)... PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ...(OTC Bulletin Board: CICI), a leading supplier of ...s automation in the financial industry* and the re...ion and Docubase Systems Inc. ("Docubase"), a lead...EDM) software provider announced today that they h...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 1Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 2Keep Oral Health in Check This School Year With the New Philips Sonicare for Kids Power Toothbrush 55519 3Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 1Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready to Use IV Bags 55516 2ANAVEX reports sigma receptor review published in leading journal 55513 1ANAVEX reports sigma receptor review published in leading journal 55513 2ANAVEX reports sigma receptor review published in leading journal 55513 3
...of the amino acid supplement L-arginine following ...nctions and measurements and may be associated wit... in the January 4 issue of JAMA. , L-arginine is a...ized as having benefits for patients with hyperten..., according to background information in the artic...
...archers at Washington University School of Medicin...Salmonella to the short list of genes regulated by...almonella riboswitch is the first to sense and res...ypes of molecules that riboswitches can detect to ... , First identified in 2002, riboswitches sense w...
...archers at Virginia Commonwealth University,s Mass..., anti-cancer agent able to overcome acquired drug...bed into cancer cells and then attacking the DNA o...earchers design a new generation of anti-cancer dr...esistance and side effects and expand the range of...
Other Biology News:Little known DNA repair enzyme may be a tumor suppressor gene 2Salmonella bacteria use RNA to assess and adjust magnesium levels 2Salmonella bacteria use RNA to assess and adjust magnesium levels 3VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum 2
(Date:12/3/2009)...PRNewswire/ -- Nikon Corporation, an innovator of ... it has signed a licensing agreement with Harvard ...ochastic Optical Reconstruction Microscopy (STORM)...on will manufacture STORM enabled microscopy syste...ikon Corporation President, Mr. Michio Kariya, and...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- Inverness Medical Innovat...ling individuals to take charge of their health at...health management, has declared a dividend of $3.0...Preferred Stock ( IMA-PB). The dividend will be pa...are equal to the quotient of (a) $3.00 divided by ...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
(Date:12/2/2009)... Peregrine Pharmaceutica...n of patient enrollment in a dose confirmation and...relapsed glioblastoma multiforme (GBM), the deadli...noclonal antibody linked to a radioisotope being d...tara specifically targets cells at the center of b...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...inancial times, good relationships with shareholde...itive relationship with current investors is espec...he best source for leading a companys next round o...t: , , Treat investors like customers! Understan...rtant in meeting their expectations. It is as impo...
...s of start-up and early-stage companies , ,In an...eadership, set business goals and prioritize steps...arly-stage companies, those activities must be acc...s their full, unwavering attention. Capital must b...erved. A business owner has to concentrate on deve...
...he University of Wisconsin-Stevens Point will rece...The WiSys Technology Foundation , an organization...Madison, has received notice from the U.S. Patent ... for a UW-Stevens Points (UWSP) associate professo...ssor of soils in UWSP s College of Natural Resour...
Other Biology Technology:Enhancing Relationships with Investors 2Management Perspectives: Outsource HR 2Management Perspectives: Outsource HR 3UW-Stevens Point Professor Receives Patent Approval For New Technology 2
Acridinium Quench Solution from Cayman Chemical
Mouse Anti-C3a / C3a des Arg Monoclonal Antibody, Unconjugated, Clone 2991 from Abcam
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Biology Products: